San Antonio Commits $1.2 Million in Settlement Funds to Expand Narcan Access Across Seven Community Partners

San Antonio City Council voted last week to allocate $1.2 million in opioid settlement proceeds across seven local nonprofits over the next five years, directing resources toward community-based overdose prevention programs that will distribute the opioid reversal drug naloxone — commonly known by the brand name Narcan — and provide related harm reduction services.

The funding plan, announced March 6, represents the city's first major deployment of money flowing from the 2021 National Opioid Settlement, a series of legal agreements with pharmaceutical manufacturers and distributors that collectively settled thousands of lawsuits filed by states, counties, and municipalities over the companies' role in fueling the opioid epidemic. San Antonio expects to receive approximately $6.1 million total through 2041, with roughly half already delivered.

For 2026, the city will distribute $379,000 among the seven partner organizations, with the option to renew funding annually for up to four additional years depending on program performance and continued settlement revenues.

Seven Organizations, One Mission

The approved funding recipients represent a cross-section of San Antonio's harm reduction and public health infrastructure. Each organization will operate under individual contracts with the city to distribute Narcan and deliver complementary services tailored to the populations they serve.

The seven partners are:

BEAT AIDS — An HIV/AIDS service organization that will integrate naloxone distribution into its existing harm reduction programming.

Bexar Area Harm Reduction Coalition — A nonprofit focused on evidence-based harm reduction strategies, including syringe service programs and overdose prevention education.

Corazon Ministries Inc. — A faith-based organization serving marginalized communities with social services and health outreach.

Rise Recovery — A peer-led recovery support organization providing services for individuals and families affected by substance use disorders.

St. Luke Missionary Baptist Church — A community institution leveraging its trusted position to reach populations that might not engage with traditional public health systems.

The University of Texas Health Science Center at San Antonio — An academic medical center positioned to bring clinical expertise and research infrastructure to community naloxone access.

Yanawana Herbolarios — A community health organization incorporating traditional healing practices into substance use and mental health support.

The diversity of these partners reflects a deliberate strategy to meet people where they are — whether that's through faith communities, academic medicine, peer support networks, or culturally specific health practices.

Beyond Naloxone: Integrated Approach to Overdose Crisis

While Narcan distribution forms the core of the funded programs, the city's approach explicitly recognizes that effective overdose prevention requires addressing interconnected health challenges. The settlement funds will also support HIV testing, infectious disease management, and other services that frequently intersect with opioid use disorder.

This integrated model aligns with public health research showing that people who use drugs often face multiple, compounding health risks. Hepatitis C, HIV, skin and soft tissue infections, and other conditions are disproportionately common among people who inject drugs. By funding organizations equipped to address these overlapping needs, San Antonio is investing in comprehensive care rather than single-issue interventions.

The naloxone itself will be distributed through what the city describes as "community programs," a flexible framework that could include street outreach, drop-in centers, recovery meetings, faith gatherings, and clinical settings depending on each organization's model.

Policy Origins: From Crisis Declaration to Funded Action

The funding approval represents the concrete implementation of policy groundwork laid in 2023, when District 5 Councilwoman Teri Castillo helped introduce a resolution formally declaring opioids a public health crisis in San Antonio. That declaration signaled a shift from viewing overdoses primarily as a law enforcement problem to treating them as a public health emergency requiring medical and social interventions.

"We have a lot of work to do to get our people healthy, and this distribution is a big step in the right direction," Castillo said at the March 6 council meeting. "I look forward to how we continue to not just treat opioid and substance abuse addiction in a silo, but see how interconnected it is in our society and as well as how it intersects with the diversion program."

Castillo's reference to interconnectedness reflects growing recognition among local policymakers that substance use disorders don't exist in isolation. They interact with housing instability, mental health conditions, chronic pain, criminal justice involvement, and economic precarity. Effective responses, in this view, must be equally multifaceted.

Her mention of "the diversion program" points to San Antonio's broader efforts to redirect people with substance use disorders away from jail and toward treatment — another policy arena where opioid settlement funds could eventually play a role if the city chooses to expand its use of the money beyond harm reduction and into criminal justice alternatives.

Settlement Structure and Spending Timeline

The $6.1 million San Antonio expects to receive through 2041 is part of a much larger national settlement totaling tens of billions of dollars. The 2021 agreements involved pharmaceutical manufacturers (most notably Purdue Pharma, Johnson & Johnson) and the three major drug distributors (Cardinal Health, McKesson, AmerisourceBergen), along with retail pharmacy chains.

These settlements allocated money to states and subdivisions — counties, cities, and towns — using formulas that accounted for local overdose death rates, prescription opioid volumes, and population. The funds are legally restricted to "opioid abatement" purposes, a broad category that includes prevention, treatment, recovery, and harm reduction but excludes general budget relief or non-addiction services.

San Antonio has received approximately $3 million so far, meaning the city is deploying about 40 percent of its existing settlement revenues in this first allocation round. The phased approach — $379,000 in year one with potential renewals — gives the city flexibility to adjust funding levels based on program outcomes and incoming settlement payments.

The five-year horizon also creates accountability mechanisms. Organizations will need to demonstrate results to secure continued funding, and the city will have opportunities to shift resources if certain approaches prove more effective than others.

National Context: Settlement Spending Accountability

San Antonio's funding decisions arrive amid intensifying national scrutiny of how states and localities are using opioid settlement proceeds. While the legal agreements require money be spent on abatement, the decentralized structure leaves thousands of individual jurisdictions making independent choices about priorities and programs.

Some communities have moved quickly to expand treatment capacity, distribute naloxone, and fund peer recovery services. Others have allocated settlement dollars to law enforcement, administrative costs, or programs with limited evidence of effectiveness. In a few high-profile cases — most notably Mississippi, which passed sweeping settlement governance reforms in early March following investigative reporting — conflicts of interest and questionable spending decisions have prompted legislative intervention.

San Antonio's transparent allocation process and focus on evidence-based harm reduction practices position the city among jurisdictions taking the settlement's abatement requirements seriously. By partnering with established nonprofits rather than creating new bureaucracies, and by prioritizing direct service delivery over administrative overhead, the city is following best practices emerging from early settlement spending nationwide.

The inclusion of academic and faith-based partners also reflects lessons learned from prior public health campaigns. UT Health Science Center brings research capacity to evaluate what works, while organizations like St. Luke Missionary Baptist Church offer trusted community access that traditional public health systems often struggle to achieve.

Harm Reduction Politics in Texas

The decision to fund overtly harm reduction organizations — particularly the Bexar Area Harm Reduction Coalition, which operates syringe service programs — carries particular significance in Texas, where harm reduction approaches have historically faced political resistance.

While several Texas cities have moved toward evidence-based harm reduction in recent years, the state legislature has been slower to embrace policies like syringe exchanges, supervised consumption sites, or other interventions that accept continued drug use as a reality while working to reduce associated harms. San Antonio's settlement spending suggests local officials see naloxone distribution as a politically sustainable entry point for broader harm reduction infrastructure.

The framing matters. By emphasizing overdose prevention and life-saving medication rather than leading with syringe access or other more controversial interventions, cities can build public and political support for harm reduction principles without triggering ideological backlash. Once naloxone distribution programs demonstrate results, the logic goes, communities may be more receptive to additional evidence-based strategies.

What Success Looks Like

The city hasn't published specific performance metrics for the funded programs, but harm reduction research offers clear benchmarks. Effective naloxone distribution programs typically measure:

Distribution volume — How many naloxone kits get into community hands.

Reversal reports — How often distributed naloxone is used to reverse overdoses (though this data can be difficult to capture systematically).

Access equity — Whether distribution reaches populations at highest risk, including people who inject drugs, people experiencing homelessness, and communities of color disproportionately affected by the overdose crisis.

Integration success — How well naloxone programs connect people who experience overdoses to treatment, recovery support, and other health services.

Training reach — The number of community members trained to recognize overdose symptoms and administer naloxone effectively.

If San Antonio's programs deliver on these measures over the next five years, the city will have a strong case for expanding settlement spending on similar initiatives. If results disappoint, the annual renewal structure allows course corrections.

Looking Ahead

San Antonio's $1.2 million commitment represents a fraction of the city's total expected settlement revenues, leaving roughly $5 million for future allocation decisions. How the city chooses to deploy those remaining funds will signal whether the current focus on harm reduction and community-based prevention expands or diversifies into treatment capacity, recovery housing, criminal justice diversion, or other priorities.

For now, seven organizations have the resources and mandate to get naloxone into the hands of people who might need it to save a life — their own or someone else's. In a crisis measured in thousands of annual deaths, those individual reversals matter.

The broader question is whether this first round of funding represents a temporary program or the foundation of a sustained, comprehensive response to San Antonio's opioid crisis. The answer will emerge over the next five years as settlement dollars flow, programs deploy, and the city measures whether investments in community-based harm reduction translate into lives saved.